A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Why autism pioneer Uta Frith wants to dismantle the spectrum
2
PCOS has been officially renamed PMOS, and it’s a momentous move
3
Asteroid to miss Earth by a quarter of the length from us to the moon
4
Neanderthals treated a dental cavity by drilling into the tooth
5
Where did the laws of physics come from? I think I've found the answer
6
A lost ancient script reveals how writing as we know it really began
7
What if the idea of the autism spectrum is completely wrong?
8
Can cloud seeding save us from water bankruptcy?
9
A vast dam across the Bering Strait could stop the AMOC collapsing
10
Doubling their genomes may have helped plants survive mass extinctions
